Ventricular-arterial coupling parameters and its prognostic value in patients with decompensated heart failure,
rehospitalization with decompensated
HF was recorded in 72 (20,3%) patients, 42 (11,8%) patients died. Ea decrease
Pre-discharge anemia as a predictor of adverse clinical outcomes in patients with acute decompensated heart failureKim M.C.,
Kim K.H.,
Cho J.Y.,
Lee K.H.,
Sim D.S.,
Yoon H.J.,
Yoon N.S.,
Hong Y.J.,
Park H.W.,
Kim J.H.,
Ahn Y.,
Jeong M.H.,
Cho J.G.,
Park J.C. -discharge anemia) and a no anemia group (n = 114). All-cause mortality and
HF re-hospitalization were compared
Soluble ST2 – biomarker for prognosis and monitoring in decompensated heart failure-decompensation /
HF rehospitalization. The potential benefits of choosing sST2 as the optimal marker for serial
DECOMPENSATED HEART FAILURE: PROGNOSTIC VALUE AND INFLUENCE OF THERAPEUTIC APPROACHES symptoms. Post-discharge, many patients receive diligent and frequent follow-up. However,
rehospitalization Comparative pharmacoeconomic analysis of medication for patients after acute decompensated heart failure-sartan+sacubitril) for patients with heart failure (
HF), stabilized after an episode of acute decompensated heart failure (ADHF